Brief: Simcere Pharmaceutical Says Approval Of Investigational New Drug For Sim0501 By U.S. FDA
04/12/2023 15:19
Dec 4 (Reuters) - Simcere Pharmaceutical Group Ltd
2096.HK :
* APPROVAL OF INVESTIGATIONAL NEW DRUG FOR SIM0501 ISSUED BY
U.S.
FOOD AND DRUG ADMINISTRATION
Further company coverage: 2096.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660